PharmaResearch Co., Ltd. (KOSDAQ:214450)
South Korea · Delayed Price · Currency is KRW 413,500
+22,500 (5.75%)
Aug 20, 2026, 3:30 PM KST
PharmaResearch Financials Overview
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 565,479 | 536,289 | 350,115 | 261,011 | 194,759 | 154,083 |
Revenue Growth | 44.14% | 53.17% | 34.14% | 34.02% | 26.40% | 41.69% |
Gross Profit Gross Profit Growth | 438,696 | 411,217 | 251,237 | 190,258 | 141,513 | 108,333 |
Operating Income Operating Income Growth | 225,166 | 212,327 | 126,051 | 92,258 | 65,916 | 52,489 |
Net Income Net Income Growth | 176,522 | 165,121 | 92,043 | 76,551 | 40,577 | 46,689 |
Earnings Per Share EPS Growth | 15890.22 | 14932.75 | 8940.87 | 7487.07 | 4067.00 | 4714.88 |
EPS Growth | 49.22% | 67.02% | 19.42% | 84.09% | -13.74% | 36.78% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Overseas Overseas Growth | 219,898 | 207,496 | 130,366 | 90,938 | 56,104 | 42,486 |
South Korea South Korea Growth | 345,581 | 328,793 | 219,749 | 170,073 | 138,654 | 111,597 |
Total Total Growth | 565,479 | 536,289 | 350,115 | 261,011 | 194,759 | 154,083 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 630,775 | 614,372 | 437,351 | 160,298 | 184,343 | 156,798 |
Total Debt Total Debt Growth | 213,750 | 213,001 | 208,786 | 34,307 | 66,768 | 65,611 |
Net Cash (Debt) Net Cash Growth | 417,025 | 401,371 | 228,565 | 125,991 | 117,575 | 91,187 |
Net Cash Growth | 68.21% | 75.60% | 81.41% | 7.16% | 28.94% | 94.61% |
Net Cash Per Share Net Cash Per Share Growth | 36058.32 | 34704.78 | 22202.30 | 11932.17 | 11785.88 | 9070.92 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 178,904 | 183,162 | 138,122 | 64,945 | 59,404 | 65,297 |
Capital Expenditures CapEx Growth | -28,997 | -29,727 | -36,415 | -12,063 | -17,257 | -20,645 |
Free Cash Flow Free Cash Flow Growth | 149,907 | 153,435 | 101,707 | 52,883 | 42,147 | 44,652 |
Free Cash Flow Growth | 53.27% | 50.86% | 92.33% | 25.47% | -5.61% | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 77.58% | 76.68% | 71.76% | 72.89% | 72.66% | 70.31% |
Operating Margin | 39.82% | 39.59% | 36.00% | 35.35% | 33.84% | 34.06% |
Pretax Margin | 42.19% | 40.37% | 33.08% | 38.58% | 27.75% | 36.37% |
Profit Margin | 31.22% | 30.79% | 26.29% | 29.33% | 20.83% | 30.30% |
FCF Margin | 26.51% | 28.61% | 29.05% | 20.26% | 21.64% | 28.98% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 20, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 3700.000 | 3700.000 | 1100.000 | 950.000 | 660.000 | 600.000 |
Dividend Per Share Growth | 236.36% | 236.36% | 15.79% | 43.94% | 10.00% | 20.00% |
Dividend Yield | 0.95% | 0.92% | 0.42% | 0.88% | 0.97% | 0.76% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 20, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 26.02 | 25.36 | 29.63 | 14.59 | 17.18 | 17.52 |
Forward PE | 25.03 | 23.96 | 22.06 | 12.55 | 10.92 | 14.49 |
P/FCF Ratio | 28.66 | 27.29 | 26.82 | 21.12 | 16.55 | 18.32 |
PS Ratio | 7.60 | 7.81 | 7.79 | 4.28 | 3.58 | 5.31 |